We have observed
9 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after May 28, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
TWO-COMPONENT ELECTRON-SELECTIVE BUFFER LAYER AND PHOTOVOLTAIC CELLS USING THE SAME
Substituted azoles, anti-viral active ingredient, pharmaceutical composition, method for the production and use thereof
SYSTEM AND METHOD FOR TRANSFERRING IMAGES ONTO SUBSTRATES
CONTAINER FOR THE DELIVERY AND DISTRIBUTION OF THE LURE OR FOOD OR PHARMACEUTICAL SUBSTANCE FOR FISH OR FOR THE DISSOLUTION OF THE SUBSTANCE IN THE AQUATIC ENVIRONMENT
CONJUGATES AND SMALL MOLECULES WHICH INTERACT WITH THE CD16A RECEPTOR
SUBSTITUTED INDOLES, ANTIVIRAL ACTIVE COMPONENT, METHOD FOR PRODUCING AND USING SAME
SUBSTITUTED 3-ARYLSULFONYL-PYRAZOLO[1,5-A]PYRIMIDINES, SEROTONIN 5-HT6 RECEPTOR ANTAGONISTS AND METHODS FOR THE PRODUCTION AND USE THEREOFAND METHODS FOR THE PRODUCTION AND USE THEREOF
SUBSTITUTED METHYL AMINES, SEROTONIN 5-HT6 RECEPTOR ANTAGONISTS, METHODS FOR THE PRODUCTION AND USE THEREOF
METHOD AND APPARATUS FOR STORING ENERGY IN ALKALINE SOLUTION